Do Patients Diagnosed With Psoriatic Arthritis Before or Concurrently With Psoriasis Have Different Disease Phenotypes and Outcomes?
- 1 July 2026
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 53 (11) , 1229-1235
Abstract
Objective: This study aimed to investigate whether patients who present with psoriatic arthritis (PsA) before or concurrently with psoriasis exhibit different baseline characteristics and disease outcomes compared with patients with classical PsA, in whom psoriasis precedes PsA. We also characterized factors contributing to the onset of psoriasis in these patients. Methods: We included patients with PsA from an observational cohort and classified them into 3 groups: classical PsA (psoriasis diagnosed before PsA), concurrent disease (psoriasis and PsA diagnosed within 1 year), and antecedent PsA (PsA diagnosed > 1 year before psoriasis). We assessed the association between these groups and 2 outcomes: mean disease activity and the course of radiographic damage. We used multivariable linear regression to estimate the adjusted 5-year mean swollen joint count (SJC) and Cox proportional hazards regression to evaluate time to radiographic progression. Cox regression was also used to identify factors associated with psoriasis onset in the antecedent PsA group. Results: Of the 1702 patients studied, 1138 (66.86%) were classified as having classical PsA, 444 (26.09%) as having concurrent PsA, and 120 (7.05%) as having antecedent PsA. These groups differed in baseline demographic and PsA-related characteristics. Compared with patients with classical PsA, those with concurrent or antecedent PsA showed no significant differences in time-averaged disease activity or time to radiographic progression. Biologic disease-modifying antirheumatic drug (bDMARD) use was associated with a reduced risk of developing psoriasis in the group with antecedent PsA. Conclusion: The relative order of psoriasis and PsA diagnosis does not significantly affect disease activity or radiographic progression. bDMARDs may influence the onset of psoriasis in patients with antecedent PsA.Keywords
This publication has 32 references indexed in Scilit:
- Subclinical psoriatic arthritis: concepts, dilemmas, and research needsAnnals of the Rheumatic Diseases, 2026
- Psoriatic dactylitis: the association with HLA genetic susceptibility markersAnnals of the Rheumatic Diseases, 2026
- Understanding the transition from psoriasis to psoriatic arthritis: the role of targeted therapyEULAR Rheumatology Open, 2025
- Do Biologic Treatments for Psoriasis Lower the Risk of Psoriatic Arthritis? A Systematic ReviewAmerican Journal of Clinical Dermatology, 2023
- Concurrent onset of skin and joint symptoms correlates with higher psoriatic arthritis disease activity: A single-center retrospective studyJournal of the American Academy of Dermatology, 2023
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbiditiesJournal of the American Academy of Dermatology, 2019
- Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studiesJournal of the American Academy of Dermatology, 2019
- HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotypeArthritis & Rheumatism, 2011
- Classification criteria for psoriatic arthritis: Development of new criteria from a large international studyArthritis & Rheumatism, 2006
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984